annual net income:
-$69.92M+$2.93M(+4.02%)Summary
- As of today (May 29, 2025), ABUS annual net profit is -$69.92 million, with the most recent change of +$2.93 million (+4.02%) on December 31, 2024.
- During the last 3 years, ABUS annual net income has risen by +$6.33 million (+8.30%).
- ABUS annual net income is now -336.13% below its all-time high of $29.61 million, reached on December 31, 2012.
Performance
ABUS Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$24.53M-$11.99M(-95.71%)Summary
- As of today (May 29, 2025), ABUS quarterly net profit is -$24.53 million, with the most recent change of -$11.99 million (-95.71%) on March 31, 2025.
- Over the past year, ABUS quarterly net income has dropped by -$6.65 million (-37.21%).
- ABUS quarterly net income is now -164.09% below its all-time high of $38.27 million, reached on December 31, 2012.
Performance
ABUS quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$76.57M-$6.65M(-9.51%)Summary
- As of today (May 29, 2025), ABUS TTM net profit is -$76.57 million, with the most recent change of -$6.65 million (-9.51%) on March 31, 2025.
- Over the past year, ABUS TTM net income has dropped by -$2.19 million (-2.94%).
- ABUS TTM net income is now -352.39% below its all-time high of $30.34 million, reached on March 31, 2013.
Performance
ABUS TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ABUS Net income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +4.0% | -37.2% | -2.9% |
3 y3 years | +8.3% | -55.6% | -1.2% |
5 y5 years | +54.5% | -76.9% | +47.0% |
ABUS Net income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -0.7% | +8.3% | -95.7% | at low | -11.2% | +0.7% |
5 y | 5-year | -9.7% | +54.5% | -95.7% | at low | -20.1% | +47.0% |
alltime | all time | -336.1% | +81.8% | -164.1% | +88.8% | -352.4% | +80.2% |
ABUS Net income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$24.53M(+95.7%) | -$76.57M(+9.5%) |
Dec 2024 | -$69.92M(-4.0%) | -$12.53M(-36.4%) | -$69.92M(-8.8%) |
Sep 2024 | - | -$19.72M(-0.4%) | -$76.70M(-0.5%) |
Jun 2024 | - | -$19.80M(+10.7%) | -$77.09M(+3.6%) |
Mar 2024 | - | -$17.88M(-7.4%) | -$74.39M(+2.1%) |
Dec 2023 | -$72.85M(+4.9%) | -$19.31M(-3.9%) | -$72.85M(-3.5%) |
Sep 2023 | - | -$20.10M(+17.6%) | -$75.47M(+3.5%) |
Jun 2023 | - | -$17.09M(+4.6%) | -$72.93M(+4.1%) |
Mar 2023 | - | -$16.34M(-25.5%) | -$70.03M(+0.8%) |
Dec 2022 | -$69.46M(-8.9%) | -$21.93M(+24.8%) | -$69.46M(+0.9%) |
Sep 2022 | - | -$17.57M(+23.8%) | -$68.84M(-2.3%) |
Jun 2022 | - | -$14.19M(-10.0%) | -$70.44M(-6.9%) |
Mar 2022 | - | -$15.77M(-26.1%) | -$75.63M(-0.8%) |
Dec 2021 | -$76.25M(+19.6%) | -$21.32M(+11.3%) | -$76.25M(+5.9%) |
Sep 2021 | - | -$19.16M(-1.2%) | -$71.97M(+0.6%) |
Jun 2021 | - | -$19.39M(+18.4%) | -$71.56M(+8.0%) |
Mar 2021 | - | -$16.38M(-3.9%) | -$66.27M(+4.0%) |
Dec 2020 | -$63.74M(-58.5%) | -$17.04M(-9.1%) | -$63.74M(-10.7%) |
Sep 2020 | - | -$18.75M(+33.1%) | -$71.36M(-47.2%) |
Jun 2020 | - | -$14.09M(+1.6%) | -$135.10M(-6.4%) |
Mar 2020 | - | -$13.86M(-43.8%) | -$144.33M(-6.1%) |
Dec 2019 | -$153.72M(+169.4%) | -$24.65M(-70.1%) | -$153.72M(+4.3%) |
Sep 2019 | - | -$82.50M(+253.9%) | -$147.32M(+65.0%) |
Jun 2019 | - | -$23.32M(+0.3%) | -$89.29M(+42.0%) |
Mar 2019 | - | -$23.25M(+27.4%) | -$62.88M(+10.2%) |
Dec 2018 | -$57.06M(-32.4%) | -$18.25M(-25.4%) | -$57.06M(-23.7%) |
Sep 2018 | - | -$24.47M(-891.8%) | -$74.74M(+20.8%) |
Jun 2018 | - | $3.09M(-117.7%) | -$61.87M(-25.7%) |
Mar 2018 | - | -$17.43M(-51.5%) | -$83.22M(-1.4%) |
Dec 2017 | -$84.41M(-78.0%) | -$35.93M(+209.8%) | -$84.41M(-68.4%) |
Sep 2017 | - | -$11.60M(-36.5%) | -$267.18M(-2.9%) |
Jun 2017 | - | -$18.25M(-2.0%) | -$275.17M(-28.9%) |
Mar 2017 | - | -$18.63M(-91.5%) | -$386.92M(+0.7%) |
Dec 2016 | -$384.16M(+512.5%) | -$218.69M(+1016.1%) | -$384.16M(+122.9%) |
Sep 2016 | - | -$19.59M(-84.9%) | -$172.33M(-5.2%) |
Jun 2016 | - | -$130.00M(+718.9%) | -$181.72M(+172.8%) |
Mar 2016 | - | -$15.87M(+131.4%) | -$66.60M(+6.2%) |
Dec 2015 | -$62.72M | -$6.86M(-76.3%) | -$62.72M(+1.1%) |
Sep 2015 | - | -$28.98M(+94.7%) | -$62.02M(+48.9%) |
Jun 2015 | - | -$14.89M(+24.2%) | -$41.65M(+26.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2015 | - | -$11.99M(+94.4%) | -$32.84M(-15.4%) |
Dec 2014 | -$38.84M(+176.2%) | -$6.17M(-28.3%) | -$38.84M(+10.1%) |
Sep 2014 | - | -$8.60M(+41.5%) | -$35.27M(+8.3%) |
Jun 2014 | - | -$6.08M(-66.2%) | -$32.57M(+10.4%) |
Mar 2014 | - | -$17.98M(+592.2%) | -$29.50M(+109.8%) |
Dec 2013 | -$14.06M(-147.5%) | -$2.60M(-56.0%) | -$14.06M(-152.5%) |
Sep 2013 | - | -$5.91M(+95.9%) | $26.80M(-8.3%) |
Jun 2013 | - | -$3.01M(+18.4%) | $29.22M(-3.7%) |
Mar 2013 | - | -$2.55M(-106.7%) | $30.34M(+2.1%) |
Dec 2012 | $29.61M(-393.7%) | $38.27M(-1196.3%) | $29.72M(-374.5%) |
Sep 2012 | - | -$3.49M(+84.6%) | -$10.83M(+23.7%) |
Jun 2012 | - | -$1.89M(-40.3%) | -$8.75M(-16.7%) |
Mar 2012 | - | -$3.17M(+39.0%) | -$10.51M(-0.2%) |
Dec 2011 | -$10.08M(-18.8%) | -$2.28M(+60.9%) | -$10.53M(+0.9%) |
Sep 2011 | - | -$1.42M(-61.2%) | -$10.44M(-8.2%) |
Jun 2011 | - | -$3.65M(+14.4%) | -$11.38M(-0.9%) |
Mar 2011 | - | -$3.19M(+45.6%) | -$11.48M(-7.2%) |
Dec 2010 | -$12.41M(+48.6%) | -$2.19M(-7.1%) | -$12.38M(+4.5%) |
Sep 2010 | - | -$2.35M(-37.3%) | -$11.85M(-2.4%) |
Jun 2010 | - | -$3.75M(-8.1%) | -$12.15M(+17.6%) |
Mar 2010 | - | -$4.08M(+146.1%) | -$10.33M(+30.9%) |
Dec 2009 | -$8.36M(-28.7%) | -$1.66M(-37.3%) | -$7.89M(+8.4%) |
Sep 2009 | - | -$2.65M(+36.6%) | -$7.28M(-29.5%) |
Jun 2009 | - | -$1.94M(+17.9%) | -$10.32M(-21.5%) |
Mar 2009 | - | -$1.64M(+57.2%) | -$13.14M(+10.3%) |
Dec 2008 | -$11.72M(+353.7%) | -$1.05M(-81.6%) | -$11.91M(+13.4%) |
Sep 2008 | - | -$5.69M(+19.6%) | -$10.51M(+218.0%) |
Jun 2008 | - | -$4.76M(+1028.7%) | -$3.31M(-2.0%) |
Mar 2008 | - | -$421.50K(-217.8%) | -$3.37M(+14.3%) |
Dec 2007 | -$2.58M(-114.3%) | $357.90K(-76.4%) | -$2.95M(-10.8%) |
Sep 2007 | - | $1.52M(-131.4%) | -$3.31M(-31.4%) |
Jun 2007 | - | -$4.82M | -$4.82M |
Dec 2006 | $18.08M(-324.3%) | - | - |
Dec 2005 | -$8.06M(-71.3%) | - | - |
Dec 2004 | -$28.05M(-8.4%) | - | - |
Dec 2003 | -$30.61M(-0.8%) | - | - |
Dec 2002 | -$30.87M(+120.3%) | - | - |
Dec 2001 | -$14.02M(+52.3%) | - | - |
Dec 2000 | -$9.20M(+12.6%) | - | - |
Dec 1999 | -$8.17M(-6.6%) | - | - |
Dec 1998 | -$8.75M | - | - |
FAQ
- What is Arbutus Biopharma annual net profit?
- What is the all time high annual net income for Arbutus Biopharma?
- What is Arbutus Biopharma annual net income year-on-year change?
- What is Arbutus Biopharma quarterly net profit?
- What is the all time high quarterly net income for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly net income year-on-year change?
- What is Arbutus Biopharma TTM net profit?
- What is the all time high TTM net income for Arbutus Biopharma?
- What is Arbutus Biopharma TTM net income year-on-year change?
What is Arbutus Biopharma annual net profit?
The current annual net income of ABUS is -$69.92M
What is the all time high annual net income for Arbutus Biopharma?
Arbutus Biopharma all-time high annual net profit is $29.61M
What is Arbutus Biopharma annual net income year-on-year change?
Over the past year, ABUS annual net profit has changed by +$2.93M (+4.02%)
What is Arbutus Biopharma quarterly net profit?
The current quarterly net income of ABUS is -$24.53M
What is the all time high quarterly net income for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly net profit is $38.27M
What is Arbutus Biopharma quarterly net income year-on-year change?
Over the past year, ABUS quarterly net profit has changed by -$6.65M (-37.21%)
What is Arbutus Biopharma TTM net profit?
The current TTM net income of ABUS is -$76.57M
What is the all time high TTM net income for Arbutus Biopharma?
Arbutus Biopharma all-time high TTM net profit is $30.34M
What is Arbutus Biopharma TTM net income year-on-year change?
Over the past year, ABUS TTM net profit has changed by -$2.19M (-2.94%)